Details for New Drug Application (NDA): 202788
✉ Email this page to a colleague
The generic ingredient in SUBSYS is fentanyl. There are thirty-one drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the fentanyl profile page.
Summary for 202788
Tradename: | SUBSYS |
Applicant: | Btcp Pharma |
Ingredient: | fentanyl |
Patents: | 10 |
Medical Subject Heading (MeSH) Categories for 202788
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SPRAY;SUBLINGUAL | Strength | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jan 4, 2012 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jan 25, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Jan 25, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Apr 27, 2030 | Product Flag? | Y | Substance Flag? | Delist Request? |
Complete Access Available with Subscription